Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint to Exhibit the Next-Generation VMS+ System at EuroEcho in Milan, Italy

TheNewsWire November 29, 2018

Ventripoint Diagnostics Announces Extension of Warrants

TheNewsWire November 28, 2018

HDZ NRW Heart and Diabetes Center in Germany has Begun Using VMS+ Software for Left Ventricular Volumetric Analysis

TheNewsWire November 20, 2018

Ventripoint's Product Offering is Now Extended to Include VMS+ Software for the Analysis of 3D Echo Studies

TheNewsWire November 19, 2018

Ventripoint Has Been Approved for Government Support to Aid in the Extension of VMS Technology to Provide 4D Data

TheNewsWire November 14, 2018

St. Michael's Hospital, a Leading Cardiac Centre in Canada, Orders the Ventripoint Artificial Intelligence VMS+ Complete Heart Analysis System

TheNewsWire November 12, 2018

The University of Chicago Medical Center Cardiac Department Evaluates the VMS+ Complete Heart Analysis System

TheNewsWire November 5, 2018

Ventripoint is Now Listed on the OTCQB in the United States

TheNewsWire October 24, 2018

Ventripoint Diagnostics Announces New Marketing Manager and Provides Corporate Update on Sales

TheNewsWire October 17, 2018

Ventripoint Closes First Tranche of Non-Brokered Private Placement

TheNewsWire September 5, 2018

Ventripoint Announces $1,000,000 Non-Brokered Private Placement

TheNewsWire August 15, 2018

Ventripoint Provides Corporate Update on Development of Artificial Intelligence Engine to Automate Heart Analysis

TheNewsWire August 13, 2018

Ventripoint Provides Corporate Update on Development of Next-Generation Products

TheNewsWire August 8, 2018

Ventripoint Provides Corporate Update on Sales and Marketing

TheNewsWire August 1, 2018

Mazankowski Alberta Heart Institute Starts Study Comparing Ventripoint Heart Analysis to Contrast Enhanced 2D Echocardiography

TheNewsWire July 17, 2018

MD Anderson Cancer Center is the First Hospital in USA to Order the VMS+ Complete Heart Analysis System

TheNewsWire June 5, 2018

IIROC Trading Resumption - VPT

Canada NewsWire May 16, 2018

Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System Using 2D Ultrasound

GlobeNewswire May 16, 2018

IIROC Trading Halt - VPT

Canada NewsWire May 15, 2018

Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System using 2D Ultrasound

TheNewsWire May 15, 2018